Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer.

Bibliographic Details
Corporate Authors:	United States. Agency for Health Care Policy and Research, Blue Cross and Blue Shield Association. Technology Evaluation Center
Format:	Government Document eBook
Language:	English
Published:	[Rockville, Md.] : [U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research], [1999]
Series:	Evidence report/technology assessment. Summary ; no. 4. AHCPR pub. ; no. 99-E 011.
Subjects:	Prostate > Cancer > Hormone therapy. Antiandrogens > Therapeutic use. Androgen Antagonists > therapeutic use. Cost-Benefit Analysis. Gonadotropin-Releasing Hormone > antagonists & inhibitors. Outcome Assessment (Health Care) Prostatic Neoplasms > drug therapy. Randomized Controlled Trials as Topic.
Online Access:	https://purl.fdlp.gov/GPO/LPS48106

Available Online